Evidence map›Paper›PMID 23892917›Full record

ArticleJournal of visualized experiments : JoVE2013

Genetic manipulation in Δku80 strains for functional genomic analysis of Toxoplasma gondii.

Leah M Rommereim, Miryam A Hortua Triana, Alejandra Falla, Kiah L Sanders, Rebekah B Guevara, David J Bzik, Barbara A Fox

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. RecombinantFrontiers in immunology · 2026
    Article
  2. FromiScience · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Serial Dissection of Parasite Gene Families.Infection and immunity · 2016
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Leah M RommereimDepartment of Microbiology and Immunology, The Geisel School of Medicine at Dartmouth, USA.
Miryam A Hortua Triana
Alejandra Falla
Kiah L Sanders
Rebekah B Guevara
David J Bzik
Barbara A Fox
Dartmouth College · US

Funding

HOST-MICROBE INTERACTIONST32AI007519 · NIAID · DARTMOUTH COLLEGE · PI DEBORAH A HOGAN · 1997 to 2026
$5.9M
T GONDII--PYRIMIDINE SYNTHESIS AS A CHEMOTHERAPY TARGETR01AI041930 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 1997 to 2013
$4.2M
Parasite secreted proteins control host response to Toxoplasma gondii infectionR21AI104514 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2013 to 2014
$445k
Regulated virulence and cyst maturation in Toxoplasma gondiiR21AI075931 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2008 to 2009
$440k
Enhanced homologous recombination in Toxoplasma gondiiR21AI073142 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2007 to 2008
$435k
Genetic dissection of the Toxoplasma gondii rhoptry kinomeR21AI097018 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2011 to 2012
$435k
Functional analysis of CD8 T cell immune control in Toxoplasma gondii infectionR21AI091461 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2010 to 2011
$432k
NIAID NIH HHS AI041930NIAID NIH HHS AI073142NIAID NIH HHS AI075931NIAID NIH HHS AI091461NIAID NIH HHS R01 AI041930NIAID NIH HHS R21 AI073142NIAID NIH HHS R21 AI075931NIAID NIH HHS R21 AI091461NIAID NIH HHS R21 AI097018NIAID NIH HHS R21 AI104514NIAID NIH HHS T32 AI007519
6 · The paper itself

Abstract

Targeted genetic manipulation using homologous recombination is the method of choice for functional genomic analysis to obtain a detailed view of gene function and phenotype(s). The development of mutant strains with targeted gene deletions, targeted mutations, complemented gene function, and/or tagged genes provides powerful strategies to address gene function, particularly if these genetic manipulations can be efficiently targeted to the gene locus of interest using integration mediated by double cross over homologous recombination. Due to very high rates of nonhomologous recombination, functional genomic analysis of Toxoplasma gondii has been previously limited by the absence of efficient methods for targeting gene deletions and gene replacements to specific genetic loci. Recently, we abolished the major pathway of nonhomologous recombination in type I and type II strains of T. gondii by deleting the gene encoding the KU80 protein(1,2). The Δku80 strains behave normally during tachyzoite (acute) and bradyzoite (chronic) stages in vitro and in vivo and exhibit essentially a 100% frequency of homologous recombination. The Δku80 strains make functional genomic studies feasible on the single gene as well as on the genome scale(1-4). Here, we report methods for using type I and type II Δku80Δhxgprt strains to advance gene targeting approaches in T. gondii. We outline efficient methods for generating gene deletions, gene replacements, and tagged genes by targeted insertion or deletion of the hypoxanthine-xanthine-guanine phosphoribosyltransferase (HXGPRT) selectable marker. The described gene targeting protocol can be used in a variety of ways in Δku80 strains to advance functional analysis of the parasite genome and to develop single strains that carry multiple targeted genetic manipulations. The application of this genetic method and subsequent phenotypic assays will reveal fundamental and unique aspects of the biology of T. gondii and related significant human pathogens that cause malaria (Plasmodium sp.) and cryptosporidiosis (Cryptosporidium).

Indexed as

Genome, ProtozoanAntigens, NuclearDNA-Binding ProteinsGene DeletionGene TargetingHomologous RecombinationKu AutoantigenToxoplasmaAntigens, NuclearDNA-Binding ProteinsKu AutoantigenXrcc6 protein, human

Identifiers

PMID23892917
PMCPMC3735270
OpenAlexW1968954819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.